Skip to main content

Resources

Industry Articles

Stay in the know with insight directly from industry experts and decision-makers.

Big Pharma CMOs capture strongest performance ratings for small molecule API manufacturing Press

Big Pharma CMOs capture strongest performance ratings for small molecule API manufacturing

Manufacturers benefit from having innovators as their parent companies Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – February 9, 2017 – The 2nd edition of Industry Standard Research's (ISR’s) Small Molecule API Contract Manufacturer Quality Benchmarking report…
ISR Reports
Regulatory history and reliable on-time delivery beat cost and capacity as the most important selection attributes for drug product CMOs Press

Regulatory history and reliable on-time delivery beat cost and capacity as the most important selection attributes for drug product CMOs

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – February 8, 2017 – The 2nd edition of Industry Standard Research’s (ISR’s) Drug Product Contract Manufacturer Quality Benchmarking report reveals that buyers of outsourced drug product manufacturing services…
ISR Reports
Cell Line Selection Predicted to Shift to CMOs, Double Digit Increase in Demand for the Service Press

Cell Line Selection Predicted to Shift to CMOs, Double Digit Increase in Demand for the Service

New report defines which biologic manufacturing capabilities are needed Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – October 12, 2016 – A new report from Industry Standard Research (ISR), Bioprocessing Services and Technologies Market Trends and…
ISR Reports
Sponsors and CROs Agree that Integrating Statistical Modeling and Knowledge of Past Performance into Feasibility Analyses Improves Accuracy of Results Press

Sponsors and CROs Agree that Integrating Statistical Modeling and Knowledge of Past Performance into Feasibility Analyses Improves Accuracy of Results

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – August 30, 2016 – A new report, Best Practices in Study Feasibility, from Industry Standard Research (ISR) reveals insights into how to successfully navigate many of the challenges—medical,…
ISR Reports
New ISR Report Reveals Current and Future Dynamics in Phase II/III Market, Changes Expected in Clinical Trial Spend Press

New ISR Report Reveals Current and Future Dynamics in Phase II/III Market, Changes Expected in Clinical Trial Spend

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – June 21, 2016 – Industry Standard Research has released its comprehensive new report, “Phase II/III Study Trends and Market Outlook (2016-2020),” concerning the trends, resource allocation, and market…
ISR Reports